| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
,
ARTHUR SANTORA,
NEIL BRESLAU,
ARNOLD MOSES and
ALLEN SPIEGEL
Molecular Pathophysiology Section, National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases,National Institutes of Health Bethesda, Maryland 20892;
University of Texas Health Science Center, Southwestern Medical School Dallas, Texas 75235;
State University of New York, Upstate Medical Center Syracuse, New York 13210
Address all correspondence and requests for reprints to: Allen M. Spiegel, National Institutes of Health, Building 10, Room 9C101, Bethesda, Maryland 20892.
We measured cAMP production in response to agonists in cultured skin fibroblasts from subjects with pseudohypoparathyroidism type Ib (PHP Ib; normal phenotype, resistance to PTH only, normal guanine nucleotide stimulatory coupling protein activity) and skin fibroblasts from normal subjects. There were no significant differences in basal or prostaglandin E1- and forskolin-stimulated cAMP production in PHP Ib vs. normal fibroblasts. Fibroblasts from 7 of 10 subjects with PHP Ib had significantly reduced peak cAMP responses to PTH [3.95 ± 0.88 vs. 15.9 ± 4.2 pmol/100
g protein (mean ± SD); n = 7 for both groups; P < 0.001]. PTH-stimulated cAMP production was significantly reduced in the 7 subjects with PHP Ib at all concentrations of PTH tested [3–1000 ng/ml human PTH-(1–34)]. In the other 3 subjects with PHP Ib, the cAMP response to PTH was either normal (2 subjects) or above the normal range (1 subject). Thus, skin fibroblasts from many, but not all, subjects with PHP Ib have selective resistance to PTH in terms of cAMP response. Since the defect is hormone specific and persists in culture, we suggest that an intrinsic defect in the PTH receptor may cause PTH resistance in certain subjects with PHP Ib. The cause of PTH resistance in the subjects with a normal cAMP response to PTH is not known, but the data suggest heterogeneity even within the PHP Ib subgroup.
* This work was supported in part by Grants RR-229 (Syracuse) and RR-00633 (Dallas) from the General Clinical Research Center Program of the Division of Research Resources, NIH, and NIH Grant AM-26253 (to N.B.).
Present address: CNRS ER126, Hopital Necker, 149 rue de Sevres,75015 Paris, France.
Received July 5, 1985.
This article has been cited by other articles:
![]() |
M. Bastepe and H. Juppner Pseudohypoparathyroidism, Gs{alpha}, and the GNAS Locus IBMS BoneKEy, December 1, 2005; 2(12): 20 - 32. [Full Text] [PDF] |
||||
![]() |
K. Freson, C. Thys, C. Wittevrongel, W. Proesmans, M. F. Hoylaerts, J. Vermylen, and C. Van Geet Pseudohypoparathyroidism type Ib with disturbed imprinting in the GNAS1 cluster and Gs{alpha} deficiency in platelets Hum. Mol. Genet., October 15, 2002; 11(22): 2741 - 2750. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Weinstein, S. Yu, D. R. Warner, and J. Liu Endocrine Manifestations of Stimulatory G Protein {alpha}-Subunit Mutations and the Role of Genomic Imprinting Endocr. Rev., October 1, 2001; 22(5): 675 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Weinstein, S. Yu, and C. A. Ecelbarger Variable imprinting of the heterotrimeric G protein Gs alpha -subunit within different segments of the nephron Am J Physiol Renal Physiol, April 1, 2000; 278(4): F507 - F514. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mannstadt, H. Juppner, and T. J. Gardella Receptors for PTH and PTHrP: their biological importance and functional properties Am J Physiol Renal Physiol, November 1, 1999; 277(5): F665 - F675. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Juppner, E. Schipani, M. Bastepe, D. E. C. Cole, M. L. Lawson, M. Mannstadt, G. N. Hendy, H. Plotkin, H. Koshiyama, T. Koh, et al. The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3 PNAS, September 29, 1998; 95(20): 11798 - 11803. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |